Core Viewpoint - The company, Xuan Zhu Bio-B (02575.HK), has been included in the Hang Seng Composite Index, effective March 9, 2026, reflecting investor recognition of its value and growth potential [1] Group 1: Inclusion in Hang Seng Composite Index - The inclusion in the Hang Seng Composite Index is based on the quarterly review results announced by Hang Seng Indexes Company on February 13, 2026, for the period ending December 31, 2025 [1] - The Hang Seng Composite Index covers the top 95% of listed companies on the Hong Kong Stock Exchange by cumulative market capitalization [1] - Being part of the index is expected to meet the inclusion criteria for the Stock Connect programs, facilitating trading between Hong Kong and mainland Chinese investors [1] Group 2: Implications of Inclusion - The board believes that inclusion in the index will enhance the company's stock liquidity, broaden the investor base, and enrich the shareholder structure [1] - This development is anticipated to further elevate the company's reputation and investment value in the capital market, contributing to its long-term stable growth [1]
轩竹生物-B(02575.HK)获纳入恒生综合指数成份股